Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00118131 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

49

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: docetaxel

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]
[object Object]